| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |